Literature DB >> 10197772

Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus.

S J Augood1, H J Waldvogel, M C Münkle, R L Faull, P C Emson.   

Abstract

The distribution of messenger RNA encoding the human GAT-1 (a high-affinity GABA transporter) was investigated in the subthalamic nucleus of 10 neurologically normal human post mortem cases. Further, the distribution of messenger RNA and protein encoding the three neuronally expressed calcium-binding proteins (calbindin D28k, parvalbumin and calretinin) was similarly investigated using in situ hybridization and immunohistochemical techniques. Cellular sites of calbindin D28k, parvalbumin, calretinin and GAT-1 messenger RNA expression were localized using human-specific oligonucleotide probes radiolabelled with [35S]dATP. Sites of protein localization were visualized using specific anti-calbindin D28k, anti-parvalbumin and anti-calretinin antisera. Examination of emulsion-coated tissue sections processed for in situ hybridization revealed an intense signal for GAT-1 messenger RNA within the human subthalamic nucleus, indeed the majority of Methylene Blue-counterstained cells were enriched in this transcript. Further, a marked heterogeneity was noted with regard to the expression of the messenger RNA's encoding the three calcium-binding proteins; this elliptical nucleus was highly enriched in parvalbumin messenger RNA-positive neurons and calretinin mRNA-positive cells but not calbindin messenger RNA-positive cells. Indeed, only an occasional calbindin messenger RNA-positive cell was detected within the mediolateral extent of the nucleus. In marked contrast, numerous parvalbumin messenger RNA-positive cells and calretinin messenger RNA-positive cells were detected and they were topographically distributed; parvalbumin messenger RNA-positive cells were highly enriched in the dorsal subthalamic nucleus extending mediolaterally; calretinin messenger RNA-positive cells were more enriched ventrally although some degree of overlap was apparent. Computer-assisted analysis of the average cross-sectional somatic area of parvalbumin, calretinin and GAT-1 messenger RNA-positive neurons revealed them all to be in the range of 300 microm2. The unique patterns of calcium-binding protein gene expression were similarly reflected at the protein level; an abundance of parvalbumin- and calretinin-immunopositive neurons were observed whereas only occasional intensely-labelled calbindin-immunopositive fibres were seen, no calbindin-immunopositive cells were detected. Single and double labelling studies show that parvalbumin-immunopositive neurons were mainly localized in the dorsal region of the nucleus, and calretinin-immunopositive neurons were mainly localized in the ventral region although there was overlap with double-labelled neurons located in the middle and dorsal regions. The significance of these findings, in particular the expression of GAT-1, a high-affinity GABA uptake protein, for basal ganglia signalling is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197772     DOI: 10.1016/s0306-4522(98)00226-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

Review 1.  Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

Authors:  A Galvan; M Kuwajima; Y Smith
Journal:  Neuroscience       Date:  2006-10-23       Impact factor: 3.590

2.  Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis.

Authors:  Luca Raiteri; Egle Paolucci; Simona Prisco; Maurizio Raiteri; Giambattista Bonanno
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  A basal ganglia-like cortical-amygdalar-hypothalamic network mediates feeding behavior.

Authors:  Marie Barbier; Sandrine Chometton; Arnaud Pautrat; Carole Miguet-Alfonsi; Frédérique Datiche; Jean Gascuel; Dominique Fellmann; Yvan Peterschmitt; Véronique Coizet; Pierre-Yves Risold
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

4.  Expression of the gamma-aminobutyric acid (GABA) plasma membrane transporter-1 in monkey and human retina.

Authors:  Giovanni Casini; Dennis W Rickman; Nicholas C Brecha
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 5.  At the heart of the interoception network: Influence of the parasubthalamic nucleus on autonomic functions and motivated behaviors.

Authors:  Tanvi Shah; Jeffery L Dunning; Candice Contet
Journal:  Neuropharmacology       Date:  2021-11-29       Impact factor: 5.250

6.  Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

Authors:  Luc Mallet; Michael Schüpbach; Karim N'Diaye; Philippe Remy; Eric Bardinet; Virginie Czernecki; Marie-Laure Welter; Antoine Pelissolo; Merle Ruberg; Yves Agid; Jérôme Yelnik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-07       Impact factor: 11.205

7.  Localization and Function of GABA Transporters GAT-1 and GAT-3 in the Basal Ganglia.

Authors:  Xiao-Tao Jin; Adriana Galvan; Thomas Wichmann; Yoland Smith
Journal:  Front Syst Neurosci       Date:  2011-07-28

Review 8.  Topographic organization of the human and non-human primate subthalamic nucleus.

Authors:  Anneke Alkemade; Alfons Schnitzler; Birte U Forstmann
Journal:  Brain Struct Funct       Date:  2015-04-29       Impact factor: 3.270

9.  Diverse and pervasive subcellular distributions for both coding and long noncoding RNAs.

Authors:  Ronit Wilk; Jack Hu; Dmitry Blotsky; Henry M Krause
Journal:  Genes Dev       Date:  2016-03-01       Impact factor: 11.361

10.  Immunological function in mice lacking the Rac-related GTPase RhoG.

Authors:  Elena Vigorito; Sarah Bell; Barbara J Hebeis; Helen Reynolds; Simon McAdam; Piers C Emson; Andrew McKenzie; Martin Turner
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.